ROR1 and B-cell chronic lymphocytic leukemia: We have recently reported that both Wnt5A, a downstream effector of the embryonic Wnt signaling pathway involved in cell fate, proliferation and migration, and its tyrosine-protein kinase transmembrane receptor ROR1 are commonly expressed in CLL cells.